Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIOMARIN PHARMACEUTICAL INC Director's Dealing 2012

Nov 19, 2012

30583_dirs_2012-11-19_a4f72620-46d6-45d1-9b71-a79b7510c166.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2012-11-19

Reporting Person: Davis George Eric (SVP, General Counsel)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2012-11-19 Common Stock M 7363 $17.54 Acquired 58685 Direct
2012-11-19 Common Stock S 7363 $48.50 Disposed 51322 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2012-11-19 Stock Option (right to buy) Common Stock $17.54 M 7363 Disposed 2016-11-19 Common Stock (7363) Direct

Footnotes

F1: Original option grant vests 6/48ths on May 20, 2007 and 1/48th on the 20th day of every month thereafter.